All News #Library
Biotech
Edison Oncology Finishes Phase 1/2A Orotecan(TM) Trial Enrollment
20 Mar 2026 //
ACCESSWIRE BIO
Edison Oncology To Showcase Two Posters At 2026 AACR Meeting
18 Mar 2026 //
ACCESSWIRE
Edison Oncology Unveils Data On EO1001 And EO?4426
24 Nov 2025 //
ACCESSWIRE

Market Place
Sourcing Support